Impact of dose reductions of platinum compounds on survival in stage IIIB/IV non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Yumuk, P. F. [1 ]
Teomete, M. [1 ]
Dane, F. [1 ]
Cabuk, D. [1 ]
Basaran, G. [1 ]
Turhal, N. S. [1 ]
机构：
[1] Marmara Univ, Med Sch Hosp, Istanbul, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19055
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Changing Survival and Treatment Patterns in Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC) in Alberta, Canada
    Anaka, M.
    Gibson, A.
    Dean, M.
    Elegbede, A.
    Petersen, L.
    Tudor, R.
    Sangha, R.
    Bebb, D. G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S286 - S287
  • [42] Chemotherapy of stage IIIB and IV non-small-cell lung cancer
    Cojean, I
    LeChevalier, T
    ANNALS OF ONCOLOGY, 1995, 6 : 41 - 44
  • [43] Definitive thoracic radiotherapy in oligometastatic stage IV non-small cell lung cancer (NSCLC).
    Fernandes, Annemarie Therese
    Xanthopoulos, Eric
    Handorf, Elizabeth
    Grover, Surbhi
    Sharma, Sonam
    Eaby-Sandy, Beth
    Evans, Tracey L.
    Stevenson, James
    Langer, Corey J.
    Mitra, Nandita
    Apisarnthanarax, Smith
    Lin, Lilie
    Rengan, Ramesh
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] Excision of the primary in stage IV non-small cell lung cancer (NSCLC): A feasibility study
    Dawson, A. G.
    Baines, C.
    Joshi, V.
    O'Byrne, K. J.
    Waller, D. A.
    LUNG CANCER, 2014, 83 : S78 - S78
  • [45] Excision of the primary in stage IV non-small cell lung cancer (NSCLC): A feasibility study
    Alan G Dawson
    Vijay Joshi
    David A Waller
    Journal of Cardiothoracic Surgery, 10 (Suppl 1)
  • [46] Serum autoantibodies as prognostic biomarkers for stage IV non-small cell lung cancer (NSCLC).
    Pergande, Melissa R.
    Piper, Clinton T.
    Fhied, Cristina L.
    Mahon, Brett
    Fidler, Mary J.
    Bonomi, Philip
    Borgia, Jeffrey Allen
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [47] Impact of EGFR status and treatment selection on survival of patients with stage IV non-small cell lung cancer (NSCLC) and liver metastases (LM)
    Castanon, E.
    Fusco, J.
    Arevalo, E.
    Carranza, O.
    Zubiri, L.
    Martin, P.
    Lopez-Picazo, J. M.
    Lozano, M. D.
    Gil-Bazo, I.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S836 - S836
  • [48] CIMAvax EGF vaccine for stage IIIb/IV non-small cell lung carcinoma
    Cheng, Jian Y.
    Kananathan, Ratnavelu
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (12) : 1799 - 1801
  • [49] UFT after sequential chemo and radiotherapy in patients with stage IIIB non-small cell lung cancer (NSCLC).
    Martins, R
    De Biase, P
    Toscano, E
    Madeira, D
    Pereira, C
    Cavalcante, A
    Pinel, I
    Roriz, W
    Zukin, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 689S - 689S
  • [50] Impact of surveillance frequency on survival in non-small cell lung cancer (NSCLC) survivors
    Malhotra, Jyoti
    Jabbour, Salma K.
    Pine, Sharon
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 : S347 - S350
12345